Mega Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Mega Pharma
Largest movements
- Cash +€38,561
up €38,561 (+72.6%), from €53,128 to €91,689
mainly Depreciation (+€50,555) and Stocks and contracts (+€26,305)
- Intangible fixed assets -€33,000
down €33,000 (-33.3%), from €99,000 to €66,000
- Stocks and contracts -€26,305
down €26,305 (-40.5%), from €64,981 to €38,676
- Tangible fixed assets -€17,555
down €17,555 (-27.6%), from €63,588 to €46,033
of which Furniture and vehicles: -€12,307
- Receivables within one year -€12,236
down €12,236 (-8.9%), from €138,011 to €125,774
of which Other amounts receivable: -€11,668
- Reserves -€30,878
down €30,878 (-20.5%), from €150,463 to €119,585
- Debts after one year -€13,023
down €13,023 (-32.9%), from €39,542 to €26,519
- Short-term financial debts -€10,128
down €10,128 (-18.0%), from €56,128 to €46,000
- Trade debts +€5,334
up €5,334 (+5.1%), from €103,897 to €109,230
- Gross operating margin -€34,279
down €34,279 (-20.8%), from €164,640 to €130,361
- Staff costs +€26,289
up €26,289 (+35.9%), from €73,201 to €99,490
- Financial charges -€13,643
down €13,643 (-49.5%), from €27,587 to €13,944
- Taxes -€7,970
down €7,970 (-100.0%), from €7,970 to €0
- Other operating charges -€2,244
down €2,244 (-64.2%), from €3,496 to €1,252
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €419,628 | €370,696 | -€48,932 | -11.7% |
| Fixed assets | 21/28 | €163,508 | €112,953 | -€50,555 | -30.9% |
| Intangible fixed assets | 21 | €99,000 | €66,000 | -€33,000 | -33.3% |
| Tangible fixed assets | 22/27 | €63,588 | €46,033 | -€17,555 | -27.6% |
| Plant, machinery and equipment | 23 | €15,872 | €10,624 | -€5,248 | -33.1% |
| Furniture and vehicles | 24 | €47,716 | €35,409 | -€12,307 | -25.8% |
| Financial fixed assets | 28 | €920 | €920 | = | 0.0% |
| Current assets | 29/58 | €256,120 | €257,743 | +€1,623 | +0.6% |
| Stocks and contracts in progress | 3 | €64,981 | €38,676 | -€26,305 | -40.5% |
| Stocks | 30/36 | €64,981 | €38,676 | -€26,305 | -40.5% |
| Amounts receivable within one year | 40/41 | €138,011 | €125,774 | -€12,236 | -8.9% |
| Trade receivables | 40 | €57,343 | €56,774 | -€569 | -1.0% |
| Other amounts receivable | 41 | €80,668 | €69,000 | -€11,668 | -14.5% |
| Cash at bank and in hand | 54/58 | €53,128 | €91,689 | +€38,561 | +72.6% |
| Deferred charges and accrued income | 490/1 | €0 | €1,602 | +€1,602 | |
| Total equity and liabilities | 10/49 | €419,628 | €370,696 | -€48,932 | -11.7% |
| Equity | 10/15 | €162,863 | €131,985 | -€30,878 | -19.0% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €150,463 | €119,585 | -€30,878 | -20.5% |
| Distributable reserves | 133 | €150,463 | €119,585 | -€30,878 | -20.5% |
| Profit (loss) carried forward | 14 | €0 | - | = | |
| Amounts payable | 17/49 | €256,764 | €238,710 | -€18,054 | -7.0% |
| Amounts payable after more than one year | 17 | €39,542 | €26,519 | -€13,023 | -32.9% |
| Financial debts | 170/4 | €39,542 | €26,519 | -€13,023 | -32.9% |
| Amounts payable within one year | 42/48 | €216,344 | €211,420 | -€4,924 | -2.3% |
| Current portion of amounts payable after more than one year | 42 | €29,125 | €30,717 | +€1,592 | +5.5% |
| Financial debts | 43 | €56,128 | €46,000 | -€10,128 | -18.0% |
| Credit institutions | 430/8 | €56,128 | €46,000 | -€10,128 | -18.0% |
| Trade debts | 44 | €103,897 | €109,230 | +€5,334 | +5.1% |
| Suppliers | 440/4 | €103,897 | €109,230 | +€5,334 | +5.1% |
| Taxes, remuneration and social security | 45 | €27,194 | €25,473 | -€1,722 | -6.3% |
| Taxes | 450/3 | €14,537 | €8,905 | -€5,632 | -38.7% |
| Remuneration and social security | 454/9 | €12,657 | €16,567 | +€3,911 | +30.9% |
| Other amounts payable | 47/48 | €0 | - | = | |
| Accrued charges and deferred income | 492/3 | €878 | €771 | -€107 | -12.2% |
| Remuneration, social security and pensions | 62 | €73,201 | €99,490 | +€26,289 | +35.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €50,555 | €50,555 | = | 0.0% |
| Other operating charges | 640/8 | €3,496 | €1,252 | -€2,244 | -64.2% |
| Gross operating margin | 9900 | €164,640 | €130,361 | -€34,279 | -20.8% |
| Operating profit (loss) | 9901 | €37,389 | -€20,935 | -€58,324 | |
| Financial income | 75/76B | €6,043 | €4,001 | -€2,042 | -33.8% |
| Recurring financial income | 75 | €6,043 | €4,001 | -€2,042 | -33.8% |
| Financial charges | 65/66B | €27,587 | €13,944 | -€13,643 | -49.5% |
| Recurring financial charges | 65 | €27,587 | €13,944 | -€13,643 | -49.5% |
| Profit (loss) for the period before taxes | 9903 | €15,845 | -€30,878 | -€46,723 | |
| Income taxes | 67/77 | €7,970 | €0 | -€7,970 | -100.0% |
| Profit (loss) for the period | 9904 | €7,874 | -€30,878 | -€38,752 | |
| Profit (loss) for the period to be appropriated | 9905 | €7,874 | -€30,878 | -€38,752 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.